Literature DB >> 24535082

23andMe, the Food and Drug Administration, and the future of genetic testing.

Patricia J Zettler1, Jacob S Sherkow1, Henry T Greely1.   

Abstract

Mesh：

Year:  2014        PMID： 24535082     DOI： 10.1001/jamainternmed.2013.14706

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  7 in total

Review 1.  Getting personal: Head and neck cancer management in the era of genomic medicine.

Authors:  Andrew C Birkeland; Wendy R Uhlmann; J Chad Brenner; Andrew G Shuman
Journal:  Head Neck       Date:  2015-08-13       Impact factor: 3.147

2.  The Future of DTC Genomics and the Law.

Authors:  Henry T Greely
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

3.  A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27.

Authors:  Dexter R Golinghorst; Anya E R Prince
Journal:  J Genet Couns       Date:  2019-12-18       Impact factor: 2.537

Review 4.  Polygenic Scores for ADHD: A Meta-Analysis.

Authors:  James J Li; Quanfa He
Journal:  Res Child Adolesc Psychopathol       Date:  2021-01-25

Review 5.  Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing.

Authors:  Seon-Hee Yim; Yeun-Jun Chung
Journal:  Genomics Inform       Date:  2014-12-31

6.  Personalized genetic testing as a tool for integrating ethics instruction into biology courses.

Authors:  Tenny R Zhang; Misti Ault Anderson
Journal:  J Microbiol Biol Educ       Date:  2014-12-15

7.  Patients' willingness to share digital health and non-health data for research: a cross-sectional study.

Authors:  Emily Seltzer; Jesse Goldshear; Sharath Chandra Guntuku; Dave Grande; David A Asch; Elissa V Klinger; Raina M Merchant
Journal:  BMC Med Inform Decis Mak       Date:  2019-08-08       Impact factor: 2.796
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.